Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives
Ulrich Hacker, Martin Bentler, Dorota Kaniowska, et al.
Cancers (2020) Vol. 12, Iss. 7, pp. 1889-1889
Open Access | Times Cited: 56

Showing 26-50 of 56 citing articles:

Recombinant Viral Vectors for Therapeutic Programming of Tumour Microenvironment: Advantages and Limitations
Karīna Spunde, Ksenija Korotkaja, Anna Zajakina
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2142-2142
Open Access | Times Cited: 12
Transferrin Receptor Targeted Polyplexes Completely Comprised of Sequence‐Defined Components
Teoman Benli‐Hoppe, Şurhan Göl Öztürk, Özgür Öztürk, et al.
Macromolecular Rapid Communications (2021) Vol. 43, Iss. 12
Open Access | Times Cited: 15
Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinic
Mr. Kewal Singh, Andrëw G. Brööks, Parto Toofan, et al.
Gene Therapy (2023) Vol. 31, Iss. 1-2, pp. 56-63
Closed Access | Times Cited: 6
Advances and challenges in gene therapy strategies for pediatric cancer: a comprehensive update
Amir Kian Moaveni, Maryam Amiri, Behrouz Shademan, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 2
The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
Zhiwen Wang, Juan Chen, Zhuanglin Zeng, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 10
Capsid-modified adeno-associated virus vectors as novel vaccine platform for cancer immunotherapy
Ann‐Christin Franke, Romain Hardet, Lisa Prager, et al.
Molecular Therapy — Methods & Clinical Development (2023) Vol. 29, pp. 238-253
Open Access | Times Cited: 5
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
Marion Arnaud, Sara Bobisse, Johanna Chiffelle, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 11
Multiplexing AAV Serotype-Specific Neutralizing Antibodies in Preclinical Animal Models and Humans
Hisae Kuoch, Karina Krotova, Melanie L. Graham, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 523-523
Open Access | Times Cited: 4
Advanced Materials and Delivery Systems for Enhancement of Chimeric Antigen Receptor Cells
Tingxuan Li, Ran Luo, Lina Su, et al.
Small Methods (2023) Vol. 7, Iss. 11
Open Access | Times Cited: 4
Dual-RNA controlled delivery system inhibited tumor growth by apoptosis induction and TME activation
Sibei Lei, Yan Gao, Jingmei Li, et al.
Journal of Controlled Release (2022) Vol. 344, pp. 97-112
Open Access | Times Cited: 7
Development of an Optimized Promoter System for Exosomal and Naked AAV Vector-Based Suicide Gene Therapy in Hepatocellular Carcinoma
Vijayata Singh, Subhajit Pathak, Narendra Kumar, et al.
ACS Omega (2024) Vol. 9, Iss. 28, pp. 30945-30953
Open Access | Times Cited: 1
Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors
Nima Taghizadeh Mortezaei, Adrina Habibzadeh, Zahra Rahimian, et al.
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
VEGF—Virus Interactions: Pathogenic Mechanisms and Therapeutic Applications
Cristina Sánchez-Martínez, Esther Grueso, Tania Calvo-López, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1815-1815
Open Access | Times Cited: 1
Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma
Safiya Khurshid, Akila S. Venkataramany, Matías Montes, et al.
Deleted Journal (2024) Vol. 32, Iss. 4, pp. 200908-200908
Open Access | Times Cited: 1
Synthetic Promoters in Gene Therapy: Design Approaches, Features and Applications
Valentin Artemyev, Anna Gubaeva, Anastasiia Iu. Paremskaia, et al.
Cells (2024) Vol. 13, Iss. 23, pp. 1963-1963
Open Access | Times Cited: 1
The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy
Gai Ran, Xi-lin Feng, Yilin Xie, et al.
Journal of Integrative Medicine (2021) Vol. 19, Iss. 6, pp. 515-525
Closed Access | Times Cited: 9
Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
Nadja Meumann, Christian Schmithals, Leroy Elenschneider, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 427-427
Open Access | Times Cited: 6
Adding recombinant AAVs to the cancer therapeutics mix
Patrick L. Mulcrone, Roland W. Herzog, Weidong Xiao
Molecular Therapy — Oncolytics (2022) Vol. 27, pp. 73-88
Open Access | Times Cited: 6
Adeno-associated virus-delivered alpha synuclein inhibits bladder cancer growth via the p53/p21 signaling pathway
Zhengcun Wu, Chengxing Xia, Chao Zhang, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 8-9, pp. 1193-1206
Closed Access | Times Cited: 4
AAV-Vectored Expression of the Vascular Normalizing Agents 3TSR and Fc3TSR, and the Anti-Angiogenic Bevacizumab Extends Survival in a Murine Model of End-Stage Epithelial Ovarian Carcinoma
Ashley A. Stegelmeier, Lisa A. Santry, Matthew M. Guilleman, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 362-362
Open Access | Times Cited: 4
Adeno-Associated virus 8 delivers an immunomodulatory peptide to mouse liver more efficiently than to rat liver
Yuqing Wang, Ayrea Hurley, Marco De Giorgi, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0283996-e0283996
Open Access | Times Cited: 1
Optimization of Electroporation and Adeno-Associated Virus-Mediated Generation of 2.7 kb Knock-In Livestock Blastocysts
Jason Lin, Thomas Bishop, Joseph R. Owen, et al.
GEN Biotechnology (2023) Vol. 2, Iss. 2, pp. 120-132
Closed Access | Times Cited: 1
Insights in AAV-mediated antigen-specific immunity and a strategy for AAV vaccine dose reduction through AAV-extracellular vesicle association
Ester Molina, Marcos Tejero, Ozgun F. Duzenli, et al.
Molecular Therapy — Methods & Clinical Development (2024) Vol. 32, Iss. 4, pp. 101358-101358
Open Access
The Different Aspects of Telomerase Inhibitors in Cancer Treatment
Arian Radmehr, Amir Reza Safdarian
Interdisciplinary cancer research (2024)
Closed Access
6. Themenbereich somatische Gentherapie: aus dem Labor über klinische Studien zum kommerziellen Einsatz
Boris Fehse
Nomos Verlagsgesellschaft mbH & Co. KG eBooks (2021), pp. 156-183
Open Access | Times Cited: 2

Scroll to top